Published

Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Education Health and Sport
Date: 2026-07-16
Source: OpenAlex
DOI: 10.12775/jehs.2026.94.73071
PubMed: Unavailable

Authors

Jakub Bajer Aleksandra Włodarczyk Hubert Kulawinek Julia Obersztyn Krzysztof Kasparek Marta Czech Grzegorz Kasparek Adrianna Szczecińska Wiktoria Glanert Aleksandra Mliczek Piotr Mrozek

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Neuroplasticity Mechanism of Action Receptor Pharmacology Clinical Trial Review Article Treatment-Resistant Depression Safety Toxicity Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder2026-07-16

Related papers

From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.Human psychopharmacology · 2026-09-01 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01